1.   Earlier studies showed that tight glucose control reduces the risk of blindness, kidney disease and nerve disease.

2.   Improving glucose control is a major factor in reducing the risk of diabetic complications, such as blindness, kidney failure and amputations.

3.   Pramlintide mimics amylin to improve long-term glucose control.

4.   The company conducts research on the hormone amylin, which it believes to play an important role in glucose control and is missing in millions of diabetics.